USA. Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels
USA. Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels
The Department of Health and Human Services (“HHS” or “Department”) herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in Federal workplace drug testing programs. The Department has revised the drug testing panels for both urine and oral fluid, and revised required nomenclature for laboratory and Medical Review Officer Reports. (Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS), USA, 16.01.2025)
https://www.federalregister.gov/documents/2025/01/16/2025-00425/mandatory-guidelines-for-federal-workplace-drug-testing-programs-authorized-testing-panels